Pub Date : 2021-09-02DOI: 10.1007/s11908-021-00763-0
Lior Ben-Zvi, Jeremy Hassan, Marah Andraous, Daniel Weltsch, Diklah Sebag, Michael Margulis, B. Bernfeld
{"title":"Diagnosis and Management of Osteomyelitis in Children","authors":"Lior Ben-Zvi, Jeremy Hassan, Marah Andraous, Daniel Weltsch, Diklah Sebag, Michael Margulis, B. Bernfeld","doi":"10.1007/s11908-021-00763-0","DOIUrl":"https://doi.org/10.1007/s11908-021-00763-0","url":null,"abstract":"","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":"23 1","pages":"1-13"},"PeriodicalIF":3.1,"publicationDate":"2021-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49321965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-07-13DOI: 10.1007/s11908-021-00756-z
N. Nasir, S. Sarfaraz, I. Khanum, Tehreem Ansari, A. Nasim, S. Dodani, Shobha Luxmi
{"title":"Tuberculosis in Solid Organ Transplantation: Insights from TB Endemic Areas","authors":"N. Nasir, S. Sarfaraz, I. Khanum, Tehreem Ansari, A. Nasim, S. Dodani, Shobha Luxmi","doi":"10.1007/s11908-021-00756-z","DOIUrl":"https://doi.org/10.1007/s11908-021-00756-z","url":null,"abstract":"","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2021-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49130583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-06-03DOI: 10.1007/s11908-021-00754-1
Frank Zhu, J. Ang
{"title":"Correction to: 2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease","authors":"Frank Zhu, J. Ang","doi":"10.1007/s11908-021-00754-1","DOIUrl":"https://doi.org/10.1007/s11908-021-00754-1","url":null,"abstract":"","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2021-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11908-021-00754-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48898860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-05-07DOI: 10.1007/s11908-021-00753-2
Zeinab El Boghdadly, S. Sarwar, M. Lustberg
{"title":"Infectious Challenges with Novel Antibody–Based Therapies","authors":"Zeinab El Boghdadly, S. Sarwar, M. Lustberg","doi":"10.1007/s11908-021-00753-2","DOIUrl":"https://doi.org/10.1007/s11908-021-00753-2","url":null,"abstract":"","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2021-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11908-021-00753-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45045775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-03-15DOI: 10.1007/s11908-021-00749-y
V. Raman, K. Laupland
{"title":"Challenges to Reporting the Global Trends in the Epidemiology of ICU-Treated Sepsis and Septic Shock","authors":"V. Raman, K. Laupland","doi":"10.1007/s11908-021-00749-y","DOIUrl":"https://doi.org/10.1007/s11908-021-00749-y","url":null,"abstract":"","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":"23 1","pages":"1-8"},"PeriodicalIF":3.1,"publicationDate":"2021-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11908-021-00749-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49276553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01Epub Date: 2021-08-27DOI: 10.1007/s11908-021-00758-x
Jiabi Chen, Rohan Khazanchi, Gonzalo Bearman, Jasmine R Marcelin
Purpose of review: The purpose of this study is to review racial and ethnic inequities in the incidence and prevention of healthcare-associated infections (HAIs) in the USA, identify gaps in the literature, and recommend future directions to mitigate these inequities.
Recent findings: While some existing literature has identified the presence of racial/ethnic inequities in HAI incidence and outcomes, few studies to date have evaluated whether HAI prevention efforts have mitigated these inequities. Factors contributing to inequities in HAI prevention may include unconscious bias of healthcare professionals towards minoritized patients; socioeconomic and structural inequities disparately affecting minoritized communities; the racial segregation of quality healthcare through hospital price discrimination; divergent reimbursement rates between public and private insurers; policies or performance metrics which underfund and financially penalize safety-net hospitals; and insufficient research evaluating and addressing HAI inequities.
Summary: Expansion of the literature is needed to further interrogate root causes and evaluate the impact of interventions on racial/ethnic inequities in HAI incidence. Measures to mitigate inequities might include teaching healthcare workers how to recognize and mitigate unconscious biases, expanding community resources which address the social and structural determinants of health, increasing access to preventive health services, reforming federal and institutional policies to better support safety-net hospitals and disincentivize price discrimination, and improving diversity and inclusion within the health workforce.
{"title":"Racial/Ethnic Inequities in Healthcare-associated Infections Under the Shadow of Structural Racism: Narrative Review and Call to Action.","authors":"Jiabi Chen, Rohan Khazanchi, Gonzalo Bearman, Jasmine R Marcelin","doi":"10.1007/s11908-021-00758-x","DOIUrl":"https://doi.org/10.1007/s11908-021-00758-x","url":null,"abstract":"<p><strong>Purpose of review: </strong>The purpose of this study is to review racial and ethnic inequities in the incidence and prevention of healthcare-associated infections (HAIs) in the USA, identify gaps in the literature, and recommend future directions to mitigate these inequities.</p><p><strong>Recent findings: </strong>While some existing literature has identified the presence of racial/ethnic inequities in HAI incidence and outcomes, few studies to date have evaluated whether HAI prevention efforts have mitigated these inequities. Factors contributing to inequities in HAI prevention may include unconscious bias of healthcare professionals towards minoritized patients; socioeconomic and structural inequities disparately affecting minoritized communities; the racial segregation of quality healthcare through hospital price discrimination; divergent reimbursement rates between public and private insurers; policies or performance metrics which underfund and financially penalize safety-net hospitals; and insufficient research evaluating and addressing HAI inequities.</p><p><strong>Summary: </strong>Expansion of the literature is needed to further interrogate root causes and evaluate the impact of interventions on racial/ethnic inequities in HAI incidence. Measures to mitigate inequities might include teaching healthcare workers how to recognize and mitigate unconscious biases, expanding community resources which address the social and structural determinants of health, increasing access to preventive health services, reforming federal and institutional policies to better support safety-net hospitals and disincentivize price discrimination, and improving diversity and inclusion within the health workforce.</p>","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":"23 10","pages":"17"},"PeriodicalIF":3.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11908-021-00758-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39388320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01Epub Date: 2021-10-25DOI: 10.1007/s11908-021-00765-y
Chris F Duncan, Taryn Youngstein, Marianne D Kirrane, Dagan O Lonsdale
Purpose of review: Sepsis is a leading cause of death worldwide. Groundbreaking international collaborative efforts have culminated in the widely accepted surviving sepsis guidelines, with iterative improvements in management strategies and definitions providing important advances in care for patients. Key to the diagnosis of sepsis is identification of infection, and whilst the diagnostic criteria for sepsis is now clear, the diagnosis of infection remains a challenge and there is often discordance between clinician assessments for infection.
Recent findings: We review the utility of common biochemical, microbiological and radiological tools employed by clinicians to diagnose infection and explore the difficulty of making a diagnosis of infection in severe inflammatory states through illustrative case reports. Finally, we discuss some of the novel and emerging approaches in diagnosis of infection and sepsis.
Summary: While prompt diagnosis and treatment of sepsis is essential to improve outcomes in sepsis, there remains no single tool to reliably identify or exclude infection. This contributes to unnecessary antimicrobial use that is harmful to individuals and populations. There is therefore a pressing need for novel solutions. Machine learning approaches using multiple diagnostic and clinical inputs may offer a potential solution but as yet these approaches remain experimental.
{"title":"Diagnostic Challenges in Sepsis.","authors":"Chris F Duncan, Taryn Youngstein, Marianne D Kirrane, Dagan O Lonsdale","doi":"10.1007/s11908-021-00765-y","DOIUrl":"https://doi.org/10.1007/s11908-021-00765-y","url":null,"abstract":"<p><strong>Purpose of review: </strong>Sepsis is a leading cause of death worldwide. Groundbreaking international collaborative efforts have culminated in the widely accepted surviving sepsis guidelines, with iterative improvements in management strategies and definitions providing important advances in care for patients. Key to the diagnosis of sepsis is identification of infection, and whilst the diagnostic criteria for sepsis is now clear, the diagnosis of infection remains a challenge and there is often discordance between clinician assessments for infection.</p><p><strong>Recent findings: </strong>We review the utility of common biochemical, microbiological and radiological tools employed by clinicians to diagnose infection and explore the difficulty of making a diagnosis of infection in severe inflammatory states through illustrative case reports. Finally, we discuss some of the novel and emerging approaches in diagnosis of infection and sepsis.</p><p><strong>Summary: </strong>While prompt diagnosis and treatment of sepsis is essential to improve outcomes in sepsis, there remains no single tool to reliably identify or exclude infection. This contributes to unnecessary antimicrobial use that is harmful to individuals and populations. There is therefore a pressing need for novel solutions. Machine learning approaches using multiple diagnostic and clinical inputs may offer a potential solution but as yet these approaches remain experimental.</p>","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":"23 12","pages":"22"},"PeriodicalIF":3.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544629/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39578812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01Epub Date: 2021-08-18DOI: 10.1007/s11908-021-00759-w
Mariam Assi, Salma Abbas, Priya Nori, Michelle Doll, Emily Godbout, Gonzalo Bearman, Michael P Stevens
Purpose of review: We describe the similarities between antimicrobial stewardship programs (ASPs) and infection prevention programs (IPPs), and we discuss how these similarities lend themselves to synergy between programs. We also discuss how the COVID-19 pandemic has generated further opportunities for future collaborations that could benefit both programs.
Recent findings: The COVID-19 pandemic has created new needs, such as real-time data and access to personnel important to both programs, such as information technologists and infectious diseases specialists. It has also increased concerns about rising rates of antimicrobial resistance and healthcare-associated infections, both of which overlap significantly and are key focus areas for both ASPs and IPPs. These emergent issues have highlighted the need for enhanced program infrastructure and new team models. The shift towards telecommunication and telework has facilitated the creation of enhanced infrastructures for collaboration on activities ranging from data access and reporting to providing telehealth services to remote hospitals. These enhanced infrastructures can be leveraged in future collaborative efforts between ASPs and IPPs.
Summary: Collaboration between IPPs and ASPs can mitigate setbacks experienced by health systems during the current pandemic, enhance the performance of both programs in the post-pandemic era and increase their preparedness for future pandemic threats. As health systems plan for the post-pandemic era, they should invest in opportunities for synergy between ASPs and IPPs highlighted during the pandemic.
综述目的:我们描述了抗菌药物管理计划(ASP)和感染预防计划(IPP)之间的相似之处,并讨论了这些相似之处如何使计划之间产生协同效应。我们还讨论了 COVID-19 大流行如何为未来的合作创造了更多机会,从而使这两个计划受益:COVID-19 大流行带来了新的需求,如实时数据和对两个项目都很重要的人员(如信息技术专家和传染病专家)的访问。它还增加了对抗菌药耐药性和医疗相关感染率上升的担忧,这两个问题严重重叠,是 ASP 和 IPP 的重点关注领域。这些新出现的问题凸显了加强计划基础设施和新团队模式的必要性。向远程通信和远程工作的转变促进了从数据访问和报告到向偏远医院提供远程保健服务等活动的协作基础设施的增强。小结:IPP 和 ASP 之间的合作可以减轻卫生系统在当前大流行病期间所经历的挫折,提高这两个计划在大流行病后时期的绩效,并增强其应对未来大流行病威胁的准备。在卫生系统为后大流行时代制定计划时,它们应投资于在大流行期间突出强调的联系学校项目和综合方案之间协同作用的机会。
{"title":"Infection Prevention and Antimicrobial Stewardship Program Collaboration During the COVID-19 Pandemic: a Window of Opportunity.","authors":"Mariam Assi, Salma Abbas, Priya Nori, Michelle Doll, Emily Godbout, Gonzalo Bearman, Michael P Stevens","doi":"10.1007/s11908-021-00759-w","DOIUrl":"10.1007/s11908-021-00759-w","url":null,"abstract":"<p><strong>Purpose of review: </strong>We describe the similarities between antimicrobial stewardship programs (ASPs) and infection prevention programs (IPPs), and we discuss how these similarities lend themselves to synergy between programs. We also discuss how the COVID-19 pandemic has generated further opportunities for future collaborations that could benefit both programs.</p><p><strong>Recent findings: </strong>The COVID-19 pandemic has created new needs, such as real-time data and access to personnel important to both programs, such as information technologists and infectious diseases specialists. It has also increased concerns about rising rates of antimicrobial resistance and healthcare-associated infections, both of which overlap significantly and are key focus areas for both ASPs and IPPs. These emergent issues have highlighted the need for enhanced program infrastructure and new team models. The shift towards telecommunication and telework has facilitated the creation of enhanced infrastructures for collaboration on activities ranging from data access and reporting to providing telehealth services to remote hospitals. These enhanced infrastructures can be leveraged in future collaborative efforts between ASPs and IPPs.</p><p><strong>Summary: </strong>Collaboration between IPPs and ASPs can mitigate setbacks experienced by health systems during the current pandemic, enhance the performance of both programs in the post-pandemic era and increase their preparedness for future pandemic threats. As health systems plan for the post-pandemic era, they should invest in opportunities for synergy between ASPs and IPPs highlighted during the pandemic.</p>","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":"23 10","pages":"15"},"PeriodicalIF":3.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374122/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39338892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}